Activate assets Luoxin Pharmaceuticals Group Stock (002793.SZ) holding subsidiary intends to publicly list and sell 100% equity of Lecong Pharmaceuticals.

Luoxin Pharmaceuticals Group Stock (002793.SZ) announced that its holding subsidiary Shandong Luoxin Pharmaceuticals Group Stock Group Co., Ltd. (referred to as "Shandong Luoxin") plans to sell 100% equity of its wholly-owned subsidiary Shandong Luoxin Lecong Pharmaceutical Co., Ltd. (referred to as "Lecong Pharmaceutical") through public listing at a listing price of 190 million yuan. After the completion of this transaction, the holding subsidiary Shandong Luoxin will no longer hold the equity of Lecong Pharmaceutical, and Lecong Pharmaceutical will no longer be included in the company's consolidated financial statements. The announcement stated that this transaction is beneficial for the company to optimize its asset utilization, enhance the company's profitability, and strengthen its risk management capabilities.